Free Trial

Lantern Pharma (LTRN) Insider Trading & Ownership

Lantern Pharma logo
$2.94 -0.14 (-4.55%)
(As of 11/20/2024 ET)

Lantern Pharma (NASDAQ:LTRN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.31%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$1.17 M
Get LTRN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lantern Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

LTRN Insider Buying and Selling by Quarter

Lantern Pharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/23/2024Aaron G.L. FletcherMajor ShareholderSell10,000$6.25$62,500.00  
2/28/2024Aaron G.L. FletcherMajor ShareholderSell74,297$4.85$360,340.45  
1/17/2024Aaron G.L. FletcherMajor ShareholderSell58,889$4.20$247,333.80  
11/29/2023Leslie W KreisMajor ShareholderSell145,348$3.44$499,997.12  
(Data available from 1/1/2013 forward)

LTRN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Lantern Pharma includes Aaron G.L. Fletcher, and Leslie W Kreis. Learn more on insiders at LTRN.

7.31% of Lantern Pharma stock is owned by insiders. Learn more on LTRN's insider holdings.

The following insiders have sold LTRN shares in the last 24 months: Aaron G.L. Fletcher ($670,174.25), and Leslie W Kreis ($499,997.12).

Insiders have sold a total of 288,534 Lantern Pharma shares in the last 24 months for a total of $1,170,171.37 sold.

Lantern Pharma Key Executives

  • Mr. Panna Sharma PH.D. (Age 53)
    President, CEO & Director
    Compensation: $684.38k
  • Mr. David R. Margrave (Age 63)
    CFO & Secretary
    Compensation: $442.68k
  • Dr. Kishor Gopaldas Bhatia Ph.D. (Age 69)
    Chief Scientific Officer & Scientific Consultant
    Compensation: $283.24k
  • Nicole Leber
    Investor Relations Associate, Finance & Administrative Coordinator
  • Dr. Peter L. Nara D.V.M.
    M.S., Ph.D., Co-Founder & Advisor
  • Mr. Ernest Kitt B.S.
    M.S, Head of Clinical Operations


This page (NASDAQ:LTRN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners